143 related articles for article (PubMed ID: 11913680)
1. Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Manzanal AI; Fogué L; Santón A; Martínez-Montero JC; Bellas C
Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):210-6. PubMed ID: 11913680
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Santón A; Vidal AM; Bellas C
Acta Otolaryngol; 2003 Jun; 123(5):664-8. PubMed ID: 12875592
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
[TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma.
Chen CL; Hsu MM; Hsu HC
Intervirology; 1996; 39(4):230-5. PubMed ID: 9078463
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report.
Hila L; Farah F; Ayari H; Ferjaoui M; Dehria W; Ben Jilani S
Pathol Biol (Paris); 2009 Jul; 57(5):427-9. PubMed ID: 18835109
[TBL] [Abstract][Full Text] [Related]
10. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
11. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
14. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
15. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
16. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas.
Turunen A; Rautava J; Grénman R; Syrjänen K; Syrjänen S
Oncotarget; 2017 Apr; 8(16):27328-27338. PubMed ID: 28423694
[TBL] [Abstract][Full Text] [Related]
19. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]